Enliven Therapeutics Inc (ELVN)
Stock-Based Compensation
$13.92M
Quarterly · Period ending: · USD
ELVN Stock-Based Compensation
Latest reported$13.92Mperiod ending
Latest reported$13.92Mperiod ending
ELVN Quarterly Stock-Based Comp ($95.00K → $13.92M)
Quarterly stock-based compensation
High-resolution chart · PNG
ELVN stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 13,915,000 | |
| 7,397,000 | |
| 12,311,000 | |
| 7,185,000 | |
| 7,724,000 | |
| 6,799,000 | |
| 5,339,000 | |
| 5,176,000 | |
| 5,144,000 | |
| 4,515,000 | |
| 3,056,000 | |
| 3,401,000 | |
| 4,195,000 | |
| 2,262,000 | |
| 735,000 | |
| 1,101,000 | |
| 701,000 | |
| 654,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 679,000 | |
| 642,000 | |
| 550,000 | |
| 360,000 | |
| 297,000 | |
| 310,000 | |
| 197,000 | |
| 95,000 |